IRAK-4 inhibitors.: Part III:: A series of imidazo[1,2-a] pyridines

被引：51
作者：
Buckley, George M. [1 ]
Fosbeary, Richard [1 ]
Fraser, Joanne L. [1 ]
Gowers, Lewis [1 ]
Higueruelo, Alicia P. [1 ]
James, Lynwen A. [1 ]
Jenkins, Kerry [1 ]
Mack, Stephen R. [1 ]
Morgan, Trevor [1 ]
Parry, David M. [1 ]
Pitt, William R. [1 ]
Rausch, Oliver [1 ]
Richard, Marianna D. [1 ]
Sabin, Verity [1 ]
机构：
[1] UCB, Cambridge CB21 6GS, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 12期
关键词：
IRAK; IRAK-4; inhibitor; kinase; kinase inhibitor; imidazo[1,2-a] pyridine; inflammation; anti-inflammatory; ligand efficiency; IL-1; TNF-alpha; TNF alpha; immunity;
D O I：
10.1016/j.bmcl.2008.04.042
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Following the identification of a potent IRAK inhibitor through routine project cross screening, a novel class of IRAK-4 inhibitor was established. The SAR of imidazo[1,2-a] pyridino-pyridines and benzimidazolo-pyridines was explored. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3656 / 3660
页数：5
相关论文
共 50 条
  • [41] Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II
    Desplat, Vanessa
    Moreau, Stephane
    Gay, Aurore
    Fabre, Solene Belisle
    Thiolat, Denis
    Massip, Stephane
    Macky, Gregory
    Godde, Frederic
    Mossalayi, Djavad
    Jarry, Christian
    Guillon, Jean
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2010, 25 (02) : 204 - 215
  • [42] The imidazo[1,2-a] pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors
    Stec, Markian M.
    Andrews, Kristin L.
    Bo, Yunxin
    Caenepeel, Sean
    Liao, Hongyu
    McCarter, John
    Mullady, Erin L.
    Miguel, Tisha San
    Subramanian, Raju
    Tamayo, Nuria
    Whittington, Douglas A.
    Wang, Ling
    Wu, Tian
    Zalameda, Leeanne P.
    Zhang, Nancy
    Hughes, Paul E.
    Norman, Mark H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (19) : 4136 - 4142
  • [43] 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates-A new class of HIV-1 integrase inhibitors
    Donghi, Monica
    Kinzel, Olaf D.
    Summa, Vincenzo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (07) : 1930 - 1934
  • [44] Design, synthesis and biological evaluation of 3-(imidazo[1,2-a] pyrazin-3-ylethynyl)-2-methylbenzamides as potent and selective pan-tropomyosin receptor kinase (TRK) inhibitors
    Cui, Shengyang
    Wang, Yongjin
    Wang, Yuting
    Tang, Xia
    Ren, Xiaomei
    Zhang, Lei
    Xu, Yong
    Zhang, Zhang
    Zhang, Zhi-Min
    Lu, Xiaoyun
    Ding, Ke
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 470 - 482
  • [45] 1,5-benzodiazepines Part XIII.: Substituted 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo[1,2-a][1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity
    Grossi, G
    Di Braccio, M
    Roma, G
    Ballabeni, V
    Tognolini, M
    Calcina, F
    Barocelli, E
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (12) : 933 - 944
  • [46] Discovery of 4-Aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 Inhibitors. Part I: Optimization of in Vitro Potencies and Pharmacokinetic Properties
    Lee, Ying-Shuan E.
    Chuang, Shih-Hsien
    Huang, Lynn Y. L.
    Lai, Chun-Liang
    Lin, Yu-Hsiang
    Yang, Ju-Ying
    Liu, Chia-Wei
    Yang, Sheng-chuan
    Lin, Her-Sheng
    Chang, Chia-chi
    Lai, Jun-Yu
    Jian, Pei-Shiou
    Lam, King
    Chang, Jia-Ming
    Lau, Johnson Y. N.
    Huang, Jiann-Jyh
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (10) : 4098 - 4110
  • [47] Imidazo[1,2-a]pyrazine inhibitors of phosphoinositide 3-kinase alpha (PI3Kα): 3D-QSAR analysis utilizing the Hybrid Monte Carlo algorithm to refine receptor-ligand complexes for molecular alignment
    Chadha, N.
    Jasuja, H.
    Kaur, M.
    Bahia, M. Singh
    Silakari, O.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2014, 25 (03) : 221 - 247
  • [48] Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2
    Wang, Zhen
    Zhang, Yali
    Pinkas, Daniel M.
    Fox, Alice E.
    Luo, Jinfeng
    Huang, Huocong
    Cui, Shengyang
    Xiang, Qiuping
    Xu, Tingting
    Xun, Qiuju
    Zhu, Dongsheng
    Tu, Zhengchao
    Ren, Xiaomei
    Brekken, Rolf A.
    Bullock, Alex N.
    Liang, Guang
    Ding, Ke
    Lu, Xiaoyun
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (17) : 7977 - 7990
  • [49] Inhibitors of the tyrosine kinase EphB4.: Part 1:: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines
    Bardelle, Catherine
    Cross, Darren
    Davenport, Sara
    Kettle, Jason G.
    Ko, Eun Jung
    Leach, Andrew G.
    Mortlock, Andrew
    Read, Jon
    Roberts, Nicola J.
    Robins, Peter
    Williams, Emma J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2776 - 2780
  • [50] Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents
    Giordanetto, Fabrizio
    Barlaam, Bernard
    Berglund, Susanne
    Edman, Karl
    Karlsson, Olle
    Lindberg, Jan
    Nylander, Sven
    Inghardt, Tord
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 3936 - 3943
12345